{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:48:05Z","timestamp":1783745285140,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In about 30% of infantile, juvenile, or adolescent patients with steroid-resistant nephrotic syndrome (SRNS), a monogenic cause can be identified. The histological finding in SRNS is often focal segmental glomerulosclerosis (FSGS). Genetic data on adult patients are scarce with low diagnostic yields. Exome sequencing (ES) was performed in patients with adult disease onset and a high likelihood for hereditary FSGS. A high likelihood was defined if at least one of the following criteria was present: absence of a secondary cause, \u226425 years of age\u00a0at initial manifestation, kidney biopsy with suspicion of a hereditary cause, extrarenal manifestations, and\/or positive familial history\/reported consanguinity. Patients were excluded if age at disease onset was &lt;18 years. In 7\/24 index patients with adult disease onset, a disease-causing variant could be identified by ES leading to a diagnostic yield of 29%. Eight different variants were identified in six known genes associated with monogenic kidney diseases. Six of these variants had been described before as disease-causing. In patients with a disease-causing variant, the median age at disease onset and end-stage renal disease was 26 and 38 years, respectively. The overall median time to a definite genetic diagnosis was 9 years. In 29% of patients with adult disease onset and suspected hereditary FSGS, a monogenic cause could be identified. The long delay up to the definite genetic diagnosis highlights the importance of obtaining an early genetic diagnosis to allow for personalized treatment options including weaning of immunosuppressive treatment, avoidance of repeated renal biopsy, and provision of accurate genetic counseling.<\/jats:p>","DOI":"10.1038\/s41431-020-00719-3","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T11:03:04Z","timestamp":1599217384000},"page":"262-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Identification of disease-causing variants by comprehensive genetic testing with exome sequencing in adults with suspicion of hereditary FSGS"],"prefix":"10.1038","volume":"29","author":[{"given":"Matthias Christoph","family":"Braunisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-5801","authenticated-orcid":false,"given":"Korbinian Maria","family":"Riedhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Maurice","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Draut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"G\u00fcnthner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4454-8823","authenticated-orcid":false,"given":"Matias","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Weidenbusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Lungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4542-5267","authenticated-orcid":false,"given":"Bader","family":"Alhaddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Renders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim M.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meitinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schmaderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7917-7129","authenticated-orcid":false,"given":"Julia","family":"Hoefele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"719_CR1","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.2014050489","volume":"26","author":"CE Sadowski","year":"2015","unstructured":"Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, et al. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015;26:1279\u201389.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1749-6632.2010.05817.x","volume":"1214","author":"G Benoit","year":"2010","unstructured":"Benoit G, Machuca E, Heidet L, Antignac C. Hereditary kidney diseases: highlighting the importance of classical Mendelian phenotypes. Ann N Y Acad Sci. 2010;1214:83\u201398.","journal-title":"Ann N Y Acad Sci"},{"key":"719_CR3","doi-asserted-by":"crossref","unstructured":"Ashraf S, Kudo H, Rao J, Kikuchi A, Widmeier E, Lawson JA, et al. Mutations in six nephrosis genes delineate a pathogenic pathway amenable to treatment. Nat Commun. 2018;9:1960.","DOI":"10.1038\/s41467-018-04193-w"},{"key":"719_CR4","doi-asserted-by":"crossref","unstructured":"Lepori N, Zand L, Sethi S, Fernandez-Juarez G, Fervenza FC. Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults. Clin Kidney J. 2018;11:179\u201390.","DOI":"10.1093\/ckj\/sfx143"},{"key":"719_CR5","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1093\/ndt\/gfv355","volume":"31","author":"S Lovric","year":"2016","unstructured":"Lovric S, Ashraf S, Tan W, Hildebrandt F. Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transpl. 2016;31:1802\u201313.","journal-title":"Nephrol Dial Transpl"},{"key":"719_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3389\/fped.2018.00307","volume":"6","author":"JD Varner","year":"2018","unstructured":"Varner JD, Chryst-Stangl M, Esezobor CI, Solarin A, Wu G, Lane B, et al. Genetic testing for steroid-resistant-nephrotic syndrome in an outbred population. Front Pediatrics. 2018;6:307.","journal-title":"Front Pediatrics"},{"key":"719_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.kint.2016.10.013","volume":"91","author":"A Bierzynska","year":"2017","unstructured":"Bierzynska A, McCarthy HJ, Soderquest K, Sen ES, Colby E, Ding WY, et al. Genomic and clinical profiling of a national nephrotic syndrome cohort advocates a precision medicine approach to disease management. Kidney Int. 2017;91:937\u201347.","journal-title":"Kidney Int"},{"key":"719_CR8","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ki.2014.305","volume":"86","author":"AF Malone","year":"2014","unstructured":"Malone AF, Phelan PJ, Hall G, Cetincelik U, Homstad A, Alonso AS, et al. Rare hereditary COL4A3\/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int. 2014;86:1253\u20139.","journal-title":"Kidney Int"},{"key":"719_CR9","doi-asserted-by":"crossref","unstructured":"Braunisch MC, B\u00fcttner-Herold M, G\u00fcnthner R, Satanovskij R, Riedhammer KM, Herr P-M, et al. Heterozygous COL4A3 variants in histologically diagnosed focal segmental glomerulosclerosis. Front Pediatrics. 2018;6:171.","DOI":"10.3389\/fped.2018.00171"},{"key":"719_CR10","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/S0140-6736(14)60659-0","volume":"383","author":"O Devuyst","year":"2014","unstructured":"Devuyst O, Knoers NV, Remuzzi G, Schaefer F. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet. 2014;383:1844\u201359.","journal-title":"Lancet"},{"key":"719_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1681\/ASN.2007040452","volume":"19","author":"B Hinkes","year":"2008","unstructured":"Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, et al. Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2008;19:365\u201371.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneph.2015.205","volume":"12","author":"A Vivante","year":"2016","unstructured":"Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12:133\u201346.","journal-title":"Nat Rev Nephrol"},{"key":"719_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380:142\u201351.","journal-title":"N Engl J Med"},{"key":"719_CR14","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.05260610","volume":"6","author":"S Santin","year":"2011","unstructured":"Santin S, Bullich G, Tazon-Vega B, Garcia-Maset R, Gimenez I, Silva I, et al. Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2011;6:1139\u201348.","journal-title":"Clin J Am Soc Nephrol"},{"key":"719_CR15","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.kint.2018.07.024","volume":"94","author":"O Gribouval","year":"2018","unstructured":"Gribouval O, Boyer O, Hummel A, Dantal J, Martinez F, Sberro-Soussan R, et al. Identification of genetic causes for sporadic steroid-resistant nephrotic syndrome in adults. Kidney Int. 2018;94:1013\u201322.","journal-title":"Kidney Int"},{"key":"719_CR16","doi-asserted-by":"crossref","unstructured":"Yao T, Udwan K, John R, Rana A, Haghighi A, Xu L, et al. Integration of genetic testing and pathology for the diagnosis of adults with FSGS. Clin J Am Soc Nephrol. 2019;14:213\u201323.","DOI":"10.2215\/CJN.08750718"},{"key":"719_CR17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.5858\/133.2.224","volume":"133","author":"M Haas","year":"2009","unstructured":"Haas M. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis. Arch Pathol Lab Med. 2009;133:224\u201332.","journal-title":"Arch Pathol Lab Med"},{"key":"719_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2010.483","volume":"80","author":"AS Levey","year":"2011","unstructured":"Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80:17\u201328.","journal-title":"Kidney Int"},{"key":"719_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15824","volume":"8","author":"LS Kremer","year":"2017","unstructured":"Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun. 2017;8:15824.","journal-title":"Nat Commun"},{"key":"719_CR20","doi-asserted-by":"crossref","unstructured":"Wagner M, Berutti R, Lorenz-Depiereux B, Graf E, Eckstein G, Mayr JA, et al. Mitochondrial DNA mutation analysis from exome sequencing\u2014a more holistic approach in diagnostics of suspected mitochondrial disease. J Inherit Metab Dis. 2019;42:909\u201317.","DOI":"10.1002\/jimd.12109"},{"key":"719_CR21","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1093\/bioinformatics\/bts526","volume":"28","author":"V Plagnol","year":"2012","unstructured":"Plagnol V, Curtis J, Epstein M, Mok KY, Stebbings E, Grigoriadou S, et al. A robust model for read count data in exome sequencing experiments and implications for copy number variant calling. Bioinformatics. 2012;28:2747\u201354.","journal-title":"Bioinformatics"},{"key":"719_CR22","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1172\/JCI0216242","volume":"110","author":"H Tsukaguchi","year":"2002","unstructured":"Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, et al. NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Investig. 2002;110:1659\u201366.","journal-title":"J Clin Investig"},{"key":"719_CR23","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ng.2898","volume":"46","author":"K Tory","year":"2014","unstructured":"Tory K, Menyhard DK, Woerner S, Nevo F, Gribouval O, Kerti A, et al. Mutation-dependent recessive inheritance of NPHS2-associated steroid-resistant nephrotic syndrome. Nat Genet. 2014;46:299\u2013304.","journal-title":"Nat Genet"},{"key":"719_CR24","unstructured":"Ellard S, Baple E, Berry I, Forrester N, Turnbull C, Owens M, et al. ACGS best practice guidelines for variant classification. Association for Clinical Genomics Science, 2019.2019. https:\/\/www.acgs.uk.com\/news\/acgs-best-practiceguidelines-for-variant-classification-2019\/."},{"key":"719_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med"},{"key":"719_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ng.2543","volume":"45","author":"A Kirby","year":"2013","unstructured":"Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45:299\u2013303.","journal-title":"Nat Genet"},{"key":"719_CR27","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2215\/CJN.06380613","volume":"9","author":"AJ Bleyer","year":"2014","unstructured":"Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, et al. Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol. 2014;9:527\u201335.","journal-title":"Clin J Am Soc Nephrol"},{"key":"719_CR28","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.1681\/ASN.2007040444","volume":"18","author":"K Voskarides","year":"2007","unstructured":"Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, et al. COL4A3\/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol. 2007;18:3004\u201316.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR29","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1681\/ASN.2017090958","volume":"29","author":"AS De Vriese","year":"2018","unstructured":"De Vriese AS, Sethi S, Nath KA, Glassock RJ, Fervenza FC. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018;29:759\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1053\/j.ajkd.2003.10.024","volume":"43","author":"VD D\u2019Agati","year":"2004","unstructured":"D\u2019Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis. 2004;43:368\u201382.","journal-title":"Am J Kidney Dis"},{"key":"719_CR31","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ekir.2019.12.016","volume":"5","author":"J Chun","year":"2020","unstructured":"Chun J, Wang M, Wilkins MS, Knob AU, Benjamin A, Bu L, et al. Autosomal dominant tubulointerstitial kidney disease-uromodulin misclassified as focal segmental glomerulosclerosis or hereditary glomerular disease. Kidney Int Rep. 2020;5:519\u201329.","journal-title":"Kidney Int Rep"},{"key":"719_CR32","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","volume":"10","author":"A Trautmann","year":"2015","unstructured":"Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, et al. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015;10:592\u2013600.","journal-title":"Clin J Am Soc Nephrol"},{"key":"719_CR33","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1681\/ASN.2013111155","volume":"26","author":"S Giglio","year":"2015","unstructured":"Giglio S, Provenzano A, Mazzinghi B, Becherucci F, Giunti L, Sansavini G, et al. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression. J Am Soc Nephrol. 2015;26:230\u20136.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR34","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2215\/CJN.01190210","volume":"5","author":"AK Buscher","year":"2010","unstructured":"Buscher AK, Kranz B, Buscher R, Hildebrandt F, Dworniczak B, Pennekamp P, et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol. 2010;5:2075\u201384.","journal-title":"Clin J Am Soc Nephrol"},{"key":"719_CR35","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1681\/ASN.2012020148","volume":"24","author":"J Savige","year":"2013","unstructured":"Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol. 2013;24:364\u201375.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR36","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1053\/j.ajkd.2016.10.040","volume":"70","author":"E Park","year":"2017","unstructured":"Park E, Ahn YH, Kang HG, Yoo KH, Won NH, Lee KB, et al. COQ6 mutations in children with steroid-resistant focal segmental glomerulosclerosis and sensorineural hearing loss. Am J Kidney Dis. 2017;70:139\u201344.","journal-title":"Am J Kidney Dis"},{"key":"719_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1681\/ASN.2014121240","volume":"27","author":"E Korkmaz","year":"2016","unstructured":"Korkmaz E, Lipska-Zietkiewicz BS, Boyer O, Gribouval O, Fourrage C, Tabatabaei M, et al. ADCK4-associated glomerulopathy causes adolescence-onset FSGS. J Am Soc Nephrol. 2016;27:63\u201368.","journal-title":"J Am Soc Nephrol"},{"key":"719_CR38","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.1172\/JCI69000","volume":"123","author":"S Ashraf","year":"2013","unstructured":"Ashraf S, Gee HY, Woerner S, Xie LX, Vega-Warner V, Lovric S, et al. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption. J Clin Investig. 2013;123:5179\u201389.","journal-title":"J Clin Investig"},{"key":"719_CR39","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1056\/NEJMc0800582","volume":"358","author":"G Montini","year":"2008","unstructured":"Montini G, Malaventura C, Salviati L. Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. N Engl J Med. 2008;358:2849\u201350.","journal-title":"N Engl J Med"},{"key":"719_CR40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00467-017-3838-6","volume":"34","author":"R Preston","year":"2019","unstructured":"Preston R, Stuart HM, Lennon R. Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how? Pediatr Nephrol. 2019;34:195\u2013210.","journal-title":"Pediatr Nephrol"},{"key":"719_CR41","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1590\/S0004-27302012000800011","volume":"56","author":"MS Guaragna","year":"2012","unstructured":"Guaragna MS, Lutaif AC, Bittencourt VB, Piveta CS, Soardi FC, Castro LC, et al. Frasier syndrome: four new cases with unusual presentations. Arquivos Brasileiros de Endocrinologia Metabologia. 2012;56:525\u201332.","journal-title":"Arquivos Brasileiros de Endocrinologia Metabologia"},{"key":"719_CR42","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1093\/ndt\/gfv325","volume":"31","author":"C Gast","year":"2016","unstructured":"Gast C, Pengelly RJ, Lyon M, Bunyan DJ, Seaby EG, Graham N, et al. Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dialysis Transplant. 2016;31:961\u201370.","journal-title":"Nephrol Dialysis Transplant"},{"key":"719_CR43","doi-asserted-by":"publisher","first-page":"e76360","DOI":"10.1371\/journal.pone.0076360","volume":"8","author":"R Chatterjee","year":"2013","unstructured":"Chatterjee R, Hoffman M, Cliften P, Seshan S, Liapis H, Jain S. Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuria. PLoS ONE. 2013;8:e76360.","journal-title":"PLoS ONE"},{"key":"719_CR44","doi-asserted-by":"crossref","unstructured":"Buscher AK, Celebi N, Hoyer PF, Klein HG, Weber S, Hoefele J. Mutations in INF2 may be associated with renal histology other than focal segmental glomerulosclerosis. Pediatr Nephrol. 2017;33:433\u20137.","DOI":"10.1007\/s00467-017-3811-4"},{"key":"719_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ki.2012.349","volume":"83","author":"M Barua","year":"2013","unstructured":"Barua M, Brown EJ, Charoonratana VT, Genovese G, Sun H, Pollak MR. Mutations in the INF2 gene account for a significant proportion of familial but not sporadic focal and segmental glomerulosclerosis. Kidney Int. 2013;83:316\u201322.","journal-title":"Kidney Int"},{"key":"719_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ng1297-467","volume":"17","author":"S Barbaux","year":"1997","unstructured":"Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, et al. Donor splice-site mutations in WT1 are responsible for Frasier syndrome. Nat Genet. 1997;17:467\u201370.","journal-title":"Nat Genet"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00719-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00719-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00719-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:14:01Z","timestamp":1630710841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-020-00719-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["719"],"URL":"https:\/\/doi.org\/10.1038\/s41431-020-00719-3","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"26 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}